In recent years, incidence of bloodstream infections (BSIs) has been increasing worldwide, with over 1.2 million estimated episodes of BSI per year in Europe and around 600 000 in North America [1]. Despite efforts towards early recognition and optimal management, BSIs remain one of the leading causes of death in many European and North American countries, with a mortality rate of 12-20% [1].
